# Clinical Study for Patients With Hypertension Associated With Dyslipidemia

> **NCT01764295** · PHASE3 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 150 (estimated)

## Conditions studied

- Hypertension
- Dyslipidemia

## Interventions

- **DRUG:** DWJ1276
- **DRUG:** Olmesartan
- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01764295
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2013-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764295, "Clinical Study for Patients With Hypertension Associated With Dyslipidemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01764295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*